These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31745697)

  • 41. The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study.
    Smith AB; Butow P; Olver I; Luckett T; Grimison P; Toner GC; Stockler MR; Hovey E; Stubbs J; Turner S; Hruby G; Gurney H; Alam M; Cox K; King MT
    J Cancer Surviv; 2016 Apr; 10(2):223-33. PubMed ID: 26178326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors.
    Mamoor M; Postow MA; Lavery JA; Baxi SS; Khan N; Mao JJ; Rogak LJ; Sidlow R; Thom B; Wolchok JA; Korenstein D
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.
    Hua C; Boussemart L; Mateus C; Routier E; Boutros C; Cazenave H; Viollet R; Thomas M; Roy S; Benannoune N; Tomasic G; Soria JC; Champiat S; Texier M; Lanoy E; Robert C
    JAMA Dermatol; 2016 Jan; 152(1):45-51. PubMed ID: 26501224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis.
    Brown SL; Fisher PL; Hope-Stone L; Hussain RN; Heimann H; Damato B; Cherry MG
    Psychooncology; 2020 Nov; 29(11):1864-1873. PubMed ID: 32779313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
    Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
    J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The course of symptoms of anxiety and depression from time of diagnosis up to 2 years follow-up in head and neck cancer patients treated with primary (chemo)radiation.
    van Beek FE; Jansen F; Mak L; Lissenberg-Witte BI; Buter J; Vergeer MR; Voortman J; Cuijpers P; Leemans CR; Verdonck-de Leeuw IM
    Oral Oncol; 2020 Mar; 102():104576. PubMed ID: 32028135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health-related quality of life and psychological distress in young adult survivors of childhood cancer and their association with treatment, education, and demographic factors.
    Halvorsen JF; Sund AM; Zeltzer L; Ådnanes M; Jensberg H; Eikemo TA; Lund B; Hjemdal O; Reinfjell T
    Qual Life Res; 2018 Feb; 27(2):529-537. PubMed ID: 29090422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study.
    Beesley VL; Hughes MCB; Smithers BM; Khosrotehrani K; Malt MK; von Schuckmann LA; Green AC
    J Cancer Surviv; 2020 Oct; 14(5):712-719. PubMed ID: 32519121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life.
    Trask PC; Paterson AG; Griffith KA; Riba MB; Schwartz JL
    Cancer; 2003 Aug; 98(4):854-64. PubMed ID: 12910531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term effectiveness and moderators of a web-based tailored intervention for cancer survivors on social and emotional functioning, depression, and fatigue: randomized controlled trial.
    Willems RA; Mesters I; Lechner L; Kanera IM; Bolman CAW
    J Cancer Surviv; 2017 Dec; 11(6):691-703. PubMed ID: 28698999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma Prognosis.
    Schuermeyer I; Maican A; Sharp R; Bena J; Triozzi PL; Singh AD
    JAMA Ophthalmol; 2016 Jan; 134(1):51-6. PubMed ID: 26539659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
    Paunescu AC; Copie CB; Malak S; Gouill SL; Ribrag V; Bouabdallah K; Sibon D; Rumpold G; Preau M; Mounier N; Haioun C; Jardin F; Besson C
    Ann Hematol; 2022 Feb; 101(2):317-332. PubMed ID: 34617134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.
    Robert C; Ribas A; Schachter J; Arance A; Grob JJ; Mortier L; Daud A; Carlino MS; McNeil CM; Lotem M; Larkin JMG; Lorigan P; Neyns B; Blank CU; Petrella TM; Hamid O; Su SC; Krepler C; Ibrahim N; Long GV
    Lancet Oncol; 2019 Sep; 20(9):1239-1251. PubMed ID: 31345627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
    Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
    Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alcohol consumption behaviors and neurocognitive dysfunction and emotional distress in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Brinkman TM; Lown EA; Li C; Tonning Olsson I; Marchak JG; Stuber ML; Vuotto S; Srivastava D; Nathan PC; Leisenring WM; Armstrong GT; Robison LL; Krull KR
    Addiction; 2019 Feb; 114(2):226-235. PubMed ID: 30194889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study.
    Long GV; Atkinson V; Ascierto PA; Robert C; Hassel JC; Rutkowski P; Savage KJ; Taylor F; Coon C; Gilloteau I; Dastani HB; Waxman IM; Abernethy AP
    Ann Oncol; 2016 Oct; 27(10):1940-6. PubMed ID: 27405322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
    Ribas A; Hamid O; Daud A; Hodi FS; Wolchok JD; Kefford R; Joshua AM; Patnaik A; Hwu WJ; Weber JS; Gangadhar TC; Hersey P; Dronca R; Joseph RW; Zarour H; Chmielowski B; Lawrence DP; Algazi A; Rizvi NA; Hoffner B; Mateus C; Gergich K; Lindia JA; Giannotti M; Li XN; Ebbinghaus S; Kang SP; Robert C
    JAMA; 2016 Apr; 315(15):1600-9. PubMed ID: 27092830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
    Schachter J; Ribas A; Long GV; Arance A; Grob JJ; Mortier L; Daud A; Carlino MS; McNeil C; Lotem M; Larkin J; Lorigan P; Neyns B; Blank C; Petrella TM; Hamid O; Zhou H; Ebbinghaus S; Ibrahim N; Robert C
    Lancet; 2017 Oct; 390(10105):1853-1862. PubMed ID: 28822576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Tonorezos ES; Ford JS; Wang L; Ness KK; Yasui Y; Leisenring W; Sklar CA; Robison LL; Oeffinger KC; Nathan PC; Armstrong GT; Krull K; Jones LW
    Cancer; 2019 Sep; 125(17):3059-3067. PubMed ID: 31067357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations between workability and patient-reported physical, psychological and social outcomes in breast cancer survivors: a cross-sectional study.
    Ho PJ; Hartman M; Gernaat SAM; Cook AR; Lee SC; Hupkens L; Verkooijen HM
    Support Care Cancer; 2018 Aug; 26(8):2815-2824. PubMed ID: 29511953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.